United Capital Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Sell
145,312
-3,591
-2% -$415K 0.11% 158
2025
Q4
$15.7M Buy
148,903
+26,911
+22% +$2.53M 0.09% 176
2025
Q3
$10.2M Sell
121,992
-3,702
-3% -$305K 0.07% 204
2025
Q2
$9.95M Sell
125,694
-5,176
-4% -$411K 0.08% 196
2025
Q1
$11.7M Sell
130,870
-19,206
-13% -$1.79M 0.1% 160
2024
Q4
$14.9M Sell
150,076
-8,951
-6% -$923K 0.13% 138
2024
Q3
$18.1M Sell
159,027
-8,897
-5% -$1.06M 0.15% 131
2024
Q2
$20.8M Sell
167,924
-38,756
-19% -$4.99M 0.18% 111
2024
Q1
$27.3M Sell
206,680
-33,939
-14% -$4.18M 0.22% 98
2023
Q4
$26.2M Sell
240,619
-277,085
-54% -$28.8M 0.22% 101
2023
Q3
$53.3M Buy
517,704
+16,368
+3% +$1.76M 0.35% 62
2023
Q2
$57.8M Sell
501,336
-5,760
-1% -$654K 0.32% 67
2023
Q1
$53.9M Sell
507,096
-25,001
-5% -$2.7M 0.3% 68
2022
Q4
$59M Buy
532,097
+1,385
+0.3% +$142K 0.33% 67
2022
Q3
$45.7M Sell
530,712
-9,482
-2% -$846K 0.27% 75
2022
Q2
$49.2M Buy
540,194
+196,993
+57% +$17.5M 0.27% 76
2022
Q1
$28.2M Buy
343,201
+784
+0.2% +$61.8K 0.14% 151
2021
Q4
$26.2M Sell
342,417
-15,355
-4% -$1.22M 0.12% 166
2021
Q3
$26.9M Sell
357,772
-7,019
-2% -$534K 0.13% 156
2021
Q2
$28.4M Sell
364,791
-7,468
-2% -$555K 0.14% 150
2021
Q1
$27.4M Buy
372,259
+19,584
+6% +$1.44M 0.15% 148
2020
Q4
$27.5M Buy
352,675
+10,524
+3% +$805K 0.17% 136
2020
Q3
$27.1M Buy
342,151
+10,381
+3% +$813K 0.18% 132
2020
Q2
$24.5M Buy
331,770
+13,667
+4% +$1.03M 0.18% 122
2020
Q1
$21M Sell
318,103
-56,529
-15% -$4.44M 0.17% 127
2019
Q4
$32.5M Buy
374,632
+20,591
+6% +$1.69M 0.21% 105
2019
Q3
$28.4M Sell
354,041
-279,319
-44% -$22.4M 0.2% 110
2019
Q2
$50.7M Buy
633,360
+22,149
+4% +$1.7M 0.33% 62
2019
Q1
$48.5M Sell
611,211
-834
-0.1% -$62.4K 0.34% 63
2018
Q4
$44.6M Buy
612,045
+28,270
+5% +$2M 0.35% 64
2018
Q3
$39.5M Sell
583,775
-167,290
-22% -$10.7M 0.28% 81
2018
Q2
$43.5M Sell
751,065
-1,751
-0.2% -$98.8K 0.32% 62
2018
Q1
$39.1M Buy
752,816
+40,490
+6% +$2.19M 0.3% 73
2017
Q4
$38.5M Sell
712,326
-982
-0.1% -$54.4K 0.3% 69
2017
Q3
$43.6M Buy
713,308
+3,462
+0.5% +$210K 0.37% 53
2017
Q2
$43.4M Buy
709,846
+5,085
+0.7% +$310K 0.39% 50
2017
Q1
$42.7M Sell
704,761
-3,360
-0.5% -$204K 0.4% 52
2016
Q4
$39.8M Sell
708,121
-9,625
-1% -$563K 0.39% 51
2016
Q3
$42.7M Buy
717,746
+19,695
+3% +$1.15M 0.42% 45
2016
Q2
$38.6M Buy
698,051
+6,345
+0.9% +$338K 0.39% 44
2016
Q1
$34.9M Buy
691,706
+25,979
+4% +$1.27M 0.39% 45
2015
Q4
$33.6M Sell
665,727
-10,934
-2% -$551K 0.39% 47
2015
Q3
$31.9M Buy
676,661
+114,216
+20% +$6.07M 0.38% 46
2015
Q2
$30.6M Sell
562,445
-33,341
-6% -$1.87M 0.35% 60
2015
Q1
$33.9M Buy
595,786
+228,629
+62% +$12.9M 0.41% 49
2014
Q4
$19.9M Buy
367,157
+82,935
+29% +$4.62M 0.3% 86
2014
Q3
$16.1M Buy
284,222
+7,607
+3% +$427K 0.28% 94
2014
Q2
$15.3M Sell
276,615
-25,568
-8% -$1.39M 0.28% 93
2014
Q1
$16.4M Buy
302,183
+38,694
+15% +$2M 0.35% 65
2013
Q4
$12.6M Buy
263,489
+4,974
+2% +$227K 0.43% 60
2013
Q3
$11.7M Sell
258,515
-522
-0.2% -$23.8K 0.37% 60
2013
Q2
$11.5M Buy
+259,037
New +$11.6M 0.31% 86

Other funds holding MRK

United Capital Financial Advisors's MRK Position: Q1 2026 in Review

United Capital Financial Advisors reduced its Merck (MRK) stake by 2.4% in Q1 2026, selling an estimated $415K and leaving 145,312 shares worth $17.5M. The position accounts for 0.11% of the portfolio, ranked #158.

United Capital Financial Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $59M in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • United Capital Financial Advisors held 145,312 shares of Merck worth $17.5M as of Q1 2026.
  • United Capital Financial Advisors sold 3,591 Merck shares in Q1 2026, an estimated $415K.
  • Merck made up 0.11% of United Capital Financial Advisors's portfolio in Q1 2026, its #158 holding.
  • United Capital Financial Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Merck position peaked at $59M in Q4 2022.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.